Apply for support

in page functions
[French]

Gavi’s 2016 round of applications for vaccines and health system strengthening support is now open.

When to apply

Applications will be accepted on a rolling basis. If a country misses a deadline, the application will be reviewed by the subsequent Independent Review Committee. An Expression of Interest is no longer a requirement for 2016 applications.

 

Round 1  

Round 2  

Round 3  

Deadline for application submission  

15 January 2016

1 May 2016

9 September 2016

Application review dates (Independent Review Committee)  

7-18 March 2016

17-24 June 2016

7-18 November 2016

Gavi Board/ CEO decision  

by June 2016

by November 2016

by March 2017

How to apply - instructions

Countries must submit applications through Gavi’s online country portal, which will open two months ahead of submission deadlines. Log in details will be provided directly to each country’s focal point.

To guide their 2016 applications, countries must download four separate documents for each type of Gavi support. These guidelines and instructions should be read in the following order (see flow chart for more detail):

  1. General guidelines
  2. Support-specific guidelines
  3. Application instructions
  4. Application form

APPLICATION DOCUMENTS

Click on the zip files below to download the full package of guidelines for each type of Gavi support. Alternatively, download individual documents using the table.

Type of support

General guidelines

Support-specific guidelines

Application instructions

Frequently asked questions

Full application guidelines package

HPV vaccine demonstration programme  download the document

[English]
[French]
[Spanish]
[Russian]  

download the document

[English]
[French]
[Spanish]
[Russian]  

See country portal  

download the document

[English]
[French]
[Spanish]
[Russian]  

download the document

[English]
[French]
[Spanish]
[Russian]  

HPV vaccine national introduction  download the document

[English]
[French]
[Spanish]
[Russian]  

download the document

[English]
[French]
[Spanish]
[Russian]  

download the document

[English]
[French]
[Spanish]
[Russian]  

download the document

[English]
[French]
[Spanish]
[Russian]  

Japanese encephalitis vaccine  download the document

[English]  

download the document

[English]  

download the document

[English]  

Measles 2nd dose vaccine and measles rubella vaccine  download the document

[English]
[French]  

download the document

[English]
[French]  

download the document

[English]
[French]  

Meningitis A conjugate vaccine  download the document

[English]
[French]  

download the document

[English]
[French]  

download the document

[English]
[French]  

Pneumococcal vaccine  download the document

[English]
[French]
[Russian]  

download the document

[English]
[French]
[Russian]  

download the document

[English]
[French]
[Russian]  

Rotavirus vaccine  download the document

[English]
[French]
[Russian]  

download the document

[English]
[French]
[Russian]  

download the document

[English]
[French]
[Russian]  

Yellow fever vaccine  download the document

[English]
[French]  

download the document

[English]
[French]  

download the document

[English]
[French]  

Health system strengthening  download the document

[English]
[French]  

download the document

[English]
[French]  

download the document

[English]
[French]  

download the document

[English]
[French]  

CCE Optimisation Platform  

download the document[English]
[French]  
 download the document[English]
[French]  

Independent Review Committee review criteria

Download the criteria which the IRC uses to review applications for all types of Gavi support.

Review criteria tailored to the relevant type of support are also provided in each of the support-specific guidelines.

[English][French][Spanish][Russian]  

Exceptional catalytic support

A supplementary set of guidelines is available for the time-limited opportunity to access exceptional catalytic support for the introduction of HPV, MR and/or JE vaccines for those countries that did not have the possibility to apply for these vaccines due to the timing of the vaccines’ availability.

ACCESS TO PCV FOR COUNTRIES IN ACCELERATED TRANSITION OR TRANSITIONED OUT OF GAVI SUPPORT

Countries that (a) have crossed the eligibility threshold and completed their grace year; or (b) have completely transitioned out of Gavi support, and in either case are not yet approved for pneumococcal vaccine support, will continue to be able to apply for pneumococcal vaccines through Gavi under the terms and conditions of the AMC. As of January 2016, countries that have passed the eligibility threshold but have not yet applied for pneumococcal vaccine support are as follows: Bhutan, Cuba, Indonesia, Sri Lanka, Timor-Leste, Ukraine and Vietnam.

Reprogramming of health system strengthening support

In order to tailor Gavi’s financial support to evolving needs and priorities, countries may, in certain circumstances, reprogram approved HSS funds. In the case of significant changes to the HSS grant objectives, affecting the originally approved goals, and/or significant changes to the budget (indicatively 25% or more of the total budget, or over US$10 million) a reprogramming application is required.

Guidelines and application form for reprogramming of health system strengthening (HSS) support in 2016 | [French]  

Who to contact

For any questions regarding the application guidelines please contact proposals@gavi.org or the Gavi Senior Country Manager.

 

NEWCountry portal

Learn more about Gavi’s online country portal 

NEW Cold chain equipment technology guide

How to choose cold chain solutions that match your country needs.

Download the document 

+70

In 2014, more than 70 countries were co-financing new and underused vaccines supplied by Gavi. Their contributions totalled over US$ 80 million. More than 20 countries are projected to be fully self-financing their vaccines by 2020.

Gavi

More facts...

close icon

modal window here